Remember meForgot password?
    Log in with Twitter
Press Release

The Global Orphan Drugs Market to Witness Major Growth Rate of 7.86% Due to Growing Investments

The Global Orphan Drugs Market was worth $113.99 billion in 2016 and estimated to be growing at a CAGR of 7.86%, to reach $166.40 billion by 2021.

This press release was orginally distributed by SBWire

Hyderabad, India -- (SBWIRE) -- 03/08/2018 -- The global Orphan Drugs Market is expected to reach USD 166 Billion by 2021 from an estimated value of USD 113.99 Billion in 2016 at a CAGR of 7.86%, according to a new report by Market Data Forecast, Inc.

An orphan drug is a pharmaceutical agent that has been created particularly to treat an uncommon medicinal condition, the condition itself being alluded as "Orphan Disease"; which is an illness that influences a little level of the population. Most Orphan Diseases are hereditary, and therefore, are existent all through the individual's life, regardless of the symptoms.

Browse full research report with TOC on " Orphan Drugs Market by Type (Biological and Non-Biological), by Therapeutic Application (Haematology, Neurology, Oncology, and Others) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)" at:

The Global Orphan Drugs Market is categorised based on Type and Therapeutic Application.
By Type, the market is segmented into Biological and Non-Biological. With respect to Therapeutic Application, the market can be divided into Haematology, Neurology, Oncology, and Others.

Some of the major manufacturers of the Orphan drugs market are global Orphan Drugs market are Novartis, GlaxoSmithKline, Roche, Alexion, Sanofi, Bristol Myers Squibb, Pfizer, Vertex, Celgene, and Merck.

Customize Report:

Further Key Findings From the Report Suggest:
Non-Biological Orphan Drugs Market is the leading market segment by type accounting for almost 60% of the market share.
Neurology segment accounts for almost 40% of the market and hence becoming the leading segment of Therapeutic Application.
North America leads the global market currently owing to its major investment in Healthcare and R&D activities.
Orphan Drugs Market currently occupies just 6% of the total pharmaceutical market and there is huge scope for entry of new companies.

Request for Sample:

Browse related reports by Market Data Forecast:
Antifungal Drugs Market -
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market -

About Market Data Forecast
Being a familiar face to the Fortune 500 companies in the field of market research, Market Data Forecast provides its clientele with research material through syndicated reports, consult projects and industry newsletters across various domains and verticals. Our in-house research panel comprises of industry experts, vertical/domain specialists, supported by a well-built research & data models that help in providing insights for making well-informed decisions. We have a well-established data gathering network across 100+ countries through tie-ups and collaboration's with the key personnel in value chains & local research organizations. Apart the excellent research services, we also boast of unique post-purchase services offering a 24*7 analyst support for the period of six months. Further, though a continuous feedback from our users, clients and experts, we keep on innovating ourselves in this field to support the organizations in the most efficient ways.

Contact Info:
Name: Mr. Abhishek Shukla
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

For more information on this press release visit:

Media Relations Contact

Sai Kutumbarao
Business Development Executive
Market Data Forecast
Telephone: 1-888-702-9626
Email: Click to Email Sai Kutumbarao